» Articles » PMID: 34246638

COVID-19 in Asia: Transmission Factors, Re-opening Policies, and Vaccination Simulation

Overview
Journal Environ Res
Publisher Elsevier
Date 2021 Jul 11
PMID 34246638
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

This work aims to provide insights on the COVID-19 pandemic in three prime aspects. First, we attempted to understand the association between the COVID-19 transmission rate, environmental factors (air pollution, weather, mobility), and socio-political parameters (Government Stringency Index, GSI). Second, we evaluated the efficiency of various strategies, including radical opening, intermittent lockdown, phase lift, and contact tracing, to exit the COVID-19 pandemic and get back to pre-pandemic conditions using a stochastic individual-based epidemiology model. Third, we used a deep learning approach and simulated the vaccination rate and the time for reaching herd immunity. The analysis was done based on the collected data from eight countries in Asia, including Iran, Turkey, India, Saudi Arabia, United Arab Emirates, the Philippines, South Korea, and Russia (as a transcontinental country). Our findings in the first part highlighted a noninfluential impact from the weather-driven parameters and short-term exposure to pollutants on the transmission rate; however, long-term exposure could potentially increase the risk of COVID-19 mortality rates (based on 1998-2017 p.m.2.5 data). Mobility was highly correlated with the COVID-19 transmission and based on our causal analysis reducing mobility could curb the COVID-19 transmission rate with a 6-day lag time (on average). Secondly, among all the tested policies for exiting the COVID-19 pandemic, the contact tracing was the most efficient if executed correctly. With a 2-day delay in tracing the virus hosts, a 60% successful host tracing, and a 70% contact reduction with the hosts, a pandemic will end in a year without overburdening a healthcare system with 6000 hospital beds capacity per million. Lastly, our vaccine simulations showed that the target date for achieving herd immunity significantly varied among the countries and could be delayed to October-november 2022 in countries like India and Iran (based on 60% immunized population and assuming no intermediate factors affecting the vaccination rate).

Citing Articles

Targeting Non-Eosinophilic Immunological Pathways in COPD and AECOPD: Current Insights and Therapeutic Strategies.

Razia D, Gao C, Wang C, An Y, Wang F, Liu L Int J Chron Obstruct Pulmon Dis. 2025; 20:511-532.

PMID: 40066199 PMC: 11892741. DOI: 10.2147/COPD.S506616.


Impact of COVID-19 on essential service provision for reproductive, maternal, neonatal, and child health in the Southeast Asia region: a systematic review.

Gadsden T, Sood T, Purwar P, Peiris D, Nambiar D, Downey L Lancet Reg Health Southeast Asia. 2024; 25:100357.

PMID: 39021483 PMC: 467076. DOI: 10.1016/j.lansea.2024.100357.


Dispersal history of SARS-CoV-2 variants Alpha, Delta, and Omicron (BA.1) in Spain.

Gallego-Garcia P, Hong S, Bollen N, Dellicour S, Baele G, Suchard M medRxiv. 2024; .

PMID: 39006420 PMC: 11245079. DOI: 10.1101/2024.07.01.24309632.


Dispersal history of SARS-CoV-2 in Galicia, Spain.

Gallego-Garcia P, Estevez-Gomez N, De Chiara L, Alvarino P, Juiz-Gonzalez P, Torres-Beceiro I J Med Virol. 2024; 96(7):e29773.

PMID: 38940448 PMC: 11742125. DOI: 10.1002/jmv.29773.


Dispersal history of SARS-CoV-2 in Galicia, Spain.

Gallego-Garcia P, Estevez-Gomez N, De Chiara L, Alvarino P, Juiz-Gonzalez P, Torres-Beceiro I medRxiv. 2024; .

PMID: 38463998 PMC: 10925372. DOI: 10.1101/2024.02.27.24303385.


References
1.
Tian H, Liu Y, Li Y, Wu C, Chen B, Kraemer M . An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020; 368(6491):638-642. PMC: 7164389. DOI: 10.1126/science.abb6105. View

2.
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

3.
Korber B, Fischer W, Gnanakaran S, Yoon H, Theiler J, Abfalterer W . Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020; 182(4):812-827.e19. PMC: 7332439. DOI: 10.1016/j.cell.2020.06.043. View

4.
Hao X, Cheng S, Wu D, Wu T, Lin X, Wang C . Reconstruction of the full transmission dynamics of COVID-19 in Wuhan. Nature. 2020; 584(7821):420-424. DOI: 10.1038/s41586-020-2554-8. View

5.
Han E, Tan M, Turk E, Sridhar D, Leung G, Shibuya K . Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet. 2020; 396(10261):1525-1534. PMC: 7515628. DOI: 10.1016/S0140-6736(20)32007-9. View